Cognitive Behavioral Therapy for Fear of Cancer Recurrence in Women With BRCA1/2 Gene

Clinical trial NCT06817694 · RECRUITING

Trial details

NCT number: NCT06817694
Sponsor: CHU de Quebec-Universite Laval
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Breast Cancer Susceptibility Gene (BRCA1) Mutation BRCA2 Mutation Fear of Cancer Recurrence

Start date: 2026-02-01
Primary completion: 2026-12-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.